[HTML][HTML] Hematologic dysfunction in cancer: Mechanisms, effects on antitumor immunity, and roles in disease progression
V Plackoska, D Shaban, A Nijnik - Frontiers in Immunology, 2022 - frontiersin.org
With the major advances in cancer immunology and immunotherapy, it is critical to consider
that most immune cells are short-lived and need to be continuously replenished from …
that most immune cells are short-lived and need to be continuously replenished from …
[HTML][HTML] A comparative analysis of NOX4 protein expression in malignant and non-malignant thyroid tumors
S Fenniche, M Oukabli, Y Oubaddou, H Chahdi… - Current Issues in …, 2023 - mdpi.com
The comparative analysis of the expression of the reactive oxygen species-generating
NADPH oxidase NOX4 from TCGA data shows that the NOX4 transcript is upregulated in …
NADPH oxidase NOX4 from TCGA data shows that the NOX4 transcript is upregulated in …
Zbtb46 coordinates angiogenesis and immunity to control tumor outcome
Tumor-angiogenesis and-immunity play critical roles in cancer progression and outcome. An
inverse correlation of these two hints at common regulatory mechanism (s). Here, we report …
inverse correlation of these two hints at common regulatory mechanism (s). Here, we report …
2022 年度甲状腺癌研究及诊疗新进展
渠宁， 王钰婷， 马奔， 王宇 - 中国癌症杂志, 2023 - china-oncology.com
甲状腺癌是近年来发病率显著升高的内分泌系统恶性肿瘤, 治疗以外科治疗为主,
术后根据情况辅以内分泌治疗, 放射性核素治疗, 某些情况下需辅以放疗, 靶向治疗 …
术后根据情况辅以内分泌治疗, 放射性核素治疗, 某些情况下需辅以放疗, 靶向治疗 …
Advances in basic research, clinical diagnosis and treatment of thyroid cancer in 2022
QU Ning, W Yuting, MA Ben, W Yu - China Oncology, 2023 - china-oncology.com
Thyroid cancer is a common malignancy of the endocrine system with a significantly
increased incidence in recent years. Surgical treatment is the primary treatment, followed by …
increased incidence in recent years. Surgical treatment is the primary treatment, followed by …